News: MYX Mithra Says Sells Shares In Mayne Pharma, page-58

Aside from trying to speculate a probable jump in share value tomorrow before profit takers step in , always the case with this stock , short term traders and professional bot trading latched on to stock for years now . In regards oral contraceptive's huge amound of capital invested in Nextstellis , to date sales numbers have been disappointing to say the least considering meant to be a game changing much improved contraceptive compared to earlier oral contraceptives but going by user feedback( cant see much standout improvement / difference ) much the same side effects . How much longer are women going risk their health ( side effects) or worse using any oral contraceptive , the pill first developed in 54' and approved by the US health administration FDA in 1960 . Women taking all the risk to their in trying to avoid unwanted pregnancy . Women of today mostly acutely aware equal rights than women of earlier generations . Wonder how many men would take a male version of an oral contraceptive and risk a high probability of damaging their heath . Chances of women avoiding contraceptives altogether in the not too distant future ?. Would appreciate opinions as Nextstellis play a big part in Mayne's future growth / earnings .